| Jamekia Owens, PHARMD | |
|
700 19th St S, Birmingham, AL 35233-1927 | |
| (205) 933-8101 | |
| (205) 558-7002 |
| Full Name | Jamekia Owens |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 700 19th St S, Birmingham, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023487246 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 16575 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jamekia Owens, PHARMD 700 19th St S, Birmingham, AL 35233-1927 Ph: (205) 933-8101 | Jamekia Owens, PHARMD 700 19th St S, Birmingham, AL 35233-1927 Ph: (205) 933-8101 |
News Archive
Amgen today announced that it filed a lawsuit in the United States (U.S.) District Court of Delaware against Sanofi, Aventisub LLC, formerly doing business as Aventis Pharmaceuticals Inc. (collectively "Sanofi"), and Regeneron Pharmaceuticals, Inc. ("Regeneron") for patent infringement of U.S. Patent Numbers 8,563,698, 8,829,165, and 8,859,741.
A team of researchers from Case Western Reserve University School of Medicine have discovered how uncontrolled vitamin A metabolism in the gut can cause harmful inflammation.
Weak muscles and abdominal fat are a dangerous combination for older people who have difficulty walking.
Forest Laboratories, Inc. (NYSE: FRX) and Glenmark Pharmaceuticals S.A. (Switzerland), a wholly owned subsidiary of Glenmark Pharmaceuticals India (GPL) today announced top-line results from a Phase IIb dose range-finding study of oglemilast in patients with Chronic Obstructive Pulmonary Disease (COPD). Once-daily treatment with oglemilast did not show a statistically meaningful increase from baseline compared to placebo in the primary endpoint trough FEV1, a measure of pulmonary function that is decreased in patients with COPD. Oglemilast was well tolerated at all doses studied.
3SBio Inc., a leading biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products primarily in China, today announced that it has submitted its application for a Phase I clinical trial for NuPIAO to the Chinese State Food and Drug Administration (SFDA).
› Verified 5 days ago
Katerina Elaine Pappas, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4616 Highway 280, Birmingham, AL 35242 Phone: 205-991-6248 | |
Lindsey Elmore, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 800 Lakeshore Dr, Birmingham, AL 35229 Phone: 205-726-4431 | |
Ms. Debra Mcconnell Larussa, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2000 Center Point Pkwy, Birmingham, AL 35215 Phone: 205-852-8001 Fax: 205-852-6879 | |
Dr. Joshua James Tessin, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 619 19th St S, Birmingham, AL 35249 Phone: 205-934-5350 | |
James Andrew Carr, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 700 19th Street South, Birmingham, AL 35233 Phone: 205-933-8101 Fax: 205-558-4784 | |
Betty A Morris, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5511 Highway 280, Suite 301, Birmingham, AL 35242 Phone: 205-995-8388 Fax: 205-995-8897 | |
Leanne Phillips, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 50 Medical Park Dr E, Birmingham, AL 35235 Phone: 205-915-1011 |